Flora Peyvandi/ X
Aug 3, 2026, 11:59
Flora Peyvandi: Roctavian Withdrawal Signals Adoption Challenges
Flora Peyvandi, Professor of Internal Medicine at the University of Milan, shared a post on X about a recent article she and her colleagues co-authored, published in Research and Practice in Thrombosis and Haemostasis (RPTH), adding:
“Roctavian Withdrawal: exploring the gap between innovation and healthcare system readiness in haemophilia A gene therapy – Research and Practice in Thrombosis and Haemostasis.”
Title: Roctavian Withdrawal: exploring the gap between innovation and healthcare system readiness in haemophilia A gene therapy
Authors: Matteo Nicola Dario Di Minno, Flora Peyvandi
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 19, 2026, 10:52Consuela A. Albright: The Critical Role of Black Blood Donors in Sickle Cell Treatment
-
Sep 19, 2026, 10:47Amber Yates: Inside Agios’ Partnership with the Sickle Cell Community
-
Sep 19, 2026, 10:46Anton Farkas: Mechanical Thrombectomy for Acute PE in Early Pregnancy
-
Sep 19, 2026, 10:40Marjolein Smidt: ASH Raises Ferritin Thresholds for Iron Deficiency
-
Sep 19, 2026, 10:34Nawsherwan Mohammad: ASH 2026 Guidelines Redefine How We Detect Iron Deficiency
-
Sep 19, 2026, 10:21Upcoming Podcast on Thalassaemia with The Lancet Haematology
-
Sep 19, 2026, 10:20Steve Helm: Cardiology and Anticoagulation Pharmacist Role Opens Near NYC
-
Sep 19, 2026, 10:12Omid Seidizadeh: A Great Pleasure to Speak on vWD at the 59th NordCoag Congress
-
Sep 19, 2026, 10:08Carsten Hansen: What Happens During a Sickle Cell Crisis?